These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 26551690)

  • 1. Targeting mitochondrial energy metabolism with TSPO ligands.
    Gut P
    Biochem Soc Trans; 2015 Aug; 43(4):537-42. PubMed ID: 26551690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects of TSPO ligands on mitochondrial function in mouse microglia cells.
    Bader S; Wolf L; Milenkovic VM; Gruber M; Nothdurfter C; Rupprecht R; Wetzel CH
    Psychoneuroendocrinology; 2019 Aug; 106():65-76. PubMed ID: 30954920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TSPO: kaleidoscopic 18-kDa amid biochemical pharmacology, control and targeting of mitochondria.
    Gatliff J; Campanella M
    Biochem J; 2016 Jan; 473(2):107-21. PubMed ID: 26733718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Translocator protein (18 kDa) as a pharmacological target in adipocytes to regulate glucose homeostasis.
    Li J; Papadopoulos V
    Biochem Pharmacol; 2015 Sep; 97(1):99-110. PubMed ID: 26123521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Ligands of Translocator Protein: Design and Biological Properties.
    Mokrov GV; Deeva OA; Gudasheva TA
    Curr Pharm Des; 2021; 27(2):217-237. PubMed ID: 32881658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural requirements to obtain highly potent and selective 18 kDa Translocator Protein (TSPO) Ligands.
    Taliani S; Pugliesi I; Da Settimo F
    Curr Top Med Chem; 2011; 11(7):860-86. PubMed ID: 21291396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Steroid hormone synthesis in mitochondria.
    Miller WL
    Mol Cell Endocrinol; 2013 Oct; 379(1-2):62-73. PubMed ID: 23628605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondria modulatory effects of new TSPO ligands in a cellular model of tauopathies.
    Grimm A; Lejri I; Hallé F; Schmitt M; Götz J; Bihel F; Eckert A
    J Neuroendocrinol; 2020 Jan; 32(1):e12796. PubMed ID: 31536662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The translocator protein (18kDa) and its role in neuropsychiatric disorders.
    Barichello T; Simões LR; Collodel A; Giridharan VV; Dal-Pizzol F; Macedo D; Quevedo J
    Neurosci Biobehav Rev; 2017 Dec; 83():183-199. PubMed ID: 29054730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An update into the medicinal chemistry of translocator protein (TSPO) ligands.
    Barresi E; Robello M; Costa B; Da Pozzo E; Baglini E; Salerno S; Da Settimo F; Martini C; Taliani S
    Eur J Med Chem; 2021 Jan; 209():112924. PubMed ID: 33081988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting the 18-kDa translocator protein: recent perspectives for neuroprotection.
    Da Pozzo E; Giacomelli C; Barresi E; Costa B; Taliani S; Passetti Fda S; Martini C
    Biochem Soc Trans; 2015 Aug; 43(4):559-65. PubMed ID: 26551693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondrial translocator protein (TSPO): From physiology to cardioprotection.
    Morin D; Musman J; Pons S; Berdeaux A; Ghaleh B
    Biochem Pharmacol; 2016 Apr; 105():1-13. PubMed ID: 26688086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The translocator protein (TSPO): a novel target for cancer chemotherapy.
    Austin CJ; Kahlert J; Kassiou M; Rendina LM
    Int J Biochem Cell Biol; 2013 Jul; 45(7):1212-6. PubMed ID: 23518318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Translocator protein (18 kDa): an update on its function in steroidogenesis.
    Papadopoulos V; Fan J; Zirkin B
    J Neuroendocrinol; 2018 Feb; 30(2):. PubMed ID: 28667781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The changing landscape in translocator protein (TSPO) function.
    Selvaraj V; Stocco DM
    Trends Endocrinol Metab; 2015 Jul; 26(7):341-8. PubMed ID: 25801473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Translocator protein (18 kDa) ligand PK 11195 induces transient mitochondrial Ca2+ release leading to transepithelial Cl- secretion in HT-29 human colon cancer cells.
    Ostuni MA; Ducroc R; Péranzi G; Tonon MC; Papadopoulos V; Lacapere JJ
    Biol Cell; 2007 Nov; 99(11):639-47. PubMed ID: 17561806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The mitochondrial translocator protein (TSPO): a key multifunctional molecule in the nervous system.
    El Chemali L; Akwa Y; Massaad-Massade L
    Biochem J; 2022 Jul; 479(13):1455-1466. PubMed ID: 35819398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Translocator Protein (TSPO) Affects Mitochondrial Fatty Acid Oxidation in Steroidogenic Cells.
    Tu LN; Zhao AH; Hussein M; Stocco DM; Selvaraj V
    Endocrinology; 2016 Mar; 157(3):1110-21. PubMed ID: 26741196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TSPO Ligands Boost Mitochondrial Function and Pregnenolone Synthesis.
    Lejri I; Grimm A; Hallé F; Abarghaz M; Klein C; Maitre M; Schmitt M; Bourguignon JJ; Mensah-Nyagan AG; Bihel F; Eckert A
    J Alzheimers Dis; 2019; 72(4):1045-1058. PubMed ID: 31256132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of the mitochondrial permeability transition pore by the outer membrane does not involve the peripheral benzodiazepine receptor (Translocator Protein of 18 kDa (TSPO)).
    Šileikytė J; Blachly-Dyson E; Sewell R; Carpi A; Menabò R; Di Lisa F; Ricchelli F; Bernardi P; Forte M
    J Biol Chem; 2014 May; 289(20):13769-81. PubMed ID: 24692541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.